DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 98 filers reported holding DESIGN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 3.50 and the average weighting 0.2%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STATE OF WISCONSIN INVESTMENT BOARD | 84,000 | $529,200 | 0.00% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 16,100 | $101,430 | 0.00% |
GOLDMAN SACHS GROUP INC | 447,416 | $2,818,721 | 0.00% |
WELLINGTON MANAGEMENT GROUP LLP | 502,375 | $3,164,963 | 0.00% |
BlackRock Inc. | 2,994,051 | $18,862,523 | 0.00% |
Verition Fund Management LLC | 11,786 | $74,252 | 0.00% |
TWO SIGMA ADVISERS, LP | 79,000 | $497,700 | 0.00% |
US BANCORP \DE\ | 438 | $2,759 | 0.00% |
SIGNATUREFD, LLC | 1,211 | $7,629 | 0.00% |
Parallel Advisors, LLC | 102 | $643 | 0.00% |
BANK OF AMERICA CORP /DE/ | 77,878 | $490,631 | 0.00% |
Russell Investments Group, Ltd. | 1,394 | $8,782 | 0.00% |
ROYAL BANK OF CANADA | 3,574 | $23,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 12,463 | $78,517 | 0.00% |
NORTHERN TRUST CORP | 324,738 | $2,045,849 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 15,173 | $95,590 | 0.00% |
Legal & General Group Plc | 3,127 | $19,747 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 636,845 | $4,012,123 | 0.00% |
BALYASNY ASSET MANAGEMENT L.P. | 18,499 | $116,544 | 0.00% |
External links
This page lists DESIGN THERAPEUTICS INC's shareholders in Q2 2023. To view DESIGN THERAPEUTICS INC's shareholder history, click here.